Banner - NPPA Connect
|Articles|October 24, 2012

Investigative therapy for melanoma promising

An investigative combination therapy combining chemotherapy and immunotherapy of adoptive cell transfer with tumor infiltrating lymphocytes, followed by interleukin-2, is labor-intensive but a feasible therapy with a high response rate in treated patients, according to researchers.


Latest CME